Cabbacis Adds Equity Crowdfunding Platform for IPO
Cabbacis Inc (“Cabbacis” or the “Company”), a U.S. federally-licensed tobacco product manufacturer and plant biotech company focused on harm reduction products, announced today that investors can now participate in the Company’s Regulation A (Tier 2) initial public offering (IPO) through a capital raising portal.
- Cabbacis Inc (“Cabbacis” or the “Company”), a U.S. federally-licensed tobacco product manufacturer and plant biotech company focused on harm reduction products, announced today that investors can now participate in the Company’s Regulation A (Tier 2) initial public offering (IPO) through a capital raising portal.
- The Company has strategically chosen Issuance as its Regulation A, equity crowdfunding, platform portal.
- The Issuance platform conveniently accepts credit cards, debit cards, American Express, Apple Pay, Google Pay, ACH (bank-to-bank), or wire transfers for investments.
- Subsequent to the closing of the Offering, Cabbacis will be applying to FINRA and OTC Markets Group to list its common stock on the OTCQB® Venture Market.